A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit <a rel="external noopener" href="https://www.karger.com/Article/Pdf/520099">the original URL</a>. The file type is <code>application/pdf</code>.
Macrohistory of Moyamoya Disease Analyzed Using Artificial Intelligence
<span title="2022-02-01">2022</span>
<i title="S. Karger AG">
<a target="_blank" rel="noopener" href="https://fatcat.wiki/container/43rsh2kahvc6digemicmi5ae3e" style="color: black;">Cerebrovascular Diseases</a>
</i>
Preserved Fulltext
<b><i>Introduction:</i></b> Moyamoya disease is characterized by progressive stenotic changes in the terminal segment of the internal carotid artery and the development of abnormal vascular networks called moyamoya vessels. The objective of this review was to provide a holistic view of the epidemiology, etiology, clinical findings, treatment, and pathogenesis of moyamoya disease. A literature search was performed in PubMed using the term "moyamoya disease," for articles published until 2021.
<span class="external-identifiers">
<a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.1159/000520099">doi:10.1159/000520099</a>
<a target="_blank" rel="external noopener" href="https://www.ncbi.nlm.nih.gov/pubmed/35104814">pmid:35104814</a>
<a target="_blank" rel="external noopener" href="https://fatcat.wiki/release/alo7r43pmfg4hfen2nilpmeodu">fatcat:alo7r43pmfg4hfen2nilpmeodu</a>
</span>
more »
... <i>Results:</i></b> Artificial intelligence (AI) clustering was used to classify the articles into 5 clusters: (1) pathophysiology (23.5%); (2) clinical background (37.3%); (3) imaging (13.2%); (4) treatment (17.3%); and (5) genetics (8.7%). Many articles in the "clinical background" cluster were published from the 1970s. However, in the "treatment" and "genetics" clusters, the articles were published from the 2010s through 2021. In 2011, it was confirmed that a gene called Ringin protein 213 (<i>RNF213)</i> is a susceptibility gene for moyamoya disease. Since then, tremendous progress in genomic, transcriptomic, and epigenetic profiling (e.g., methylation profiling) has resulted in new concepts for classifying moyamoya disease. Our literature survey revealed that the pathogenesis involves aberrations of multiple signaling pathways through genetic mutations and altered gene expression. <b><i>Conclusion:</i></b> We analyzed the content vectors in abstracts using AI, and reviewed the pathophysiology, clinical background, radiological features, treatments, and genetic peculiarity of moyamoya disease.
<a target="_blank" rel="noopener" href="https://web.archive.org/web/20220202205713/https://www.karger.com/Article/Pdf/520099" title="fulltext PDF download" data-goatcounter-click="serp-fulltext" data-goatcounter-title="serp-fulltext">
<button class="ui simple right pointing dropdown compact black labeled icon button serp-button">
<i class="icon ia-icon"></i>
Web Archive
[PDF]
<div class="menu fulltext-thumbnail">
<img src="https://blobs.fatcat.wiki/thumbnail/pdf/f5/ed/f5ed3d5f0df8945882e7ce935571f561db6f9219.180px.jpg" alt="fulltext thumbnail" loading="lazy">
</div>
</button>
</a>
<a target="_blank" rel="external noopener noreferrer" href="https://doi.org/10.1159/000520099">
<button class="ui left aligned compact blue labeled icon button serp-button">
<i class="external alternate icon"></i>
Publisher / doi.org
</button>
</a>